Zinc in the retina

Progress in Neurobiology

Volumn 64, Issue 3, 2001, Pages 219-249

  Ugarte, Marta ^a   Osborne, Neville N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE TRIPHOSPHATE; ALLOPURINOL; ALPHA TOCOPHEROL; ASCORBIC ACID; BETAXOLOL; CATALASE; CATION CHANNEL; CHOLINE ACETYLTRANSFERASE; DEFEROXAMINE; DIZOCILPINE; FLUNARIZINE; GINKGO BILOBA EXTRACT; GLYCINE RECEPTOR; KAINIC ACID; MANNITOL; MELATONIN; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIFEDIPINE; OXIDIZING AGENT; RETINOL DEHYDROGENASE; RHODOPSIN; SUPEROXIDE DISMUTASE; TETRODOTOXIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; VIGABATRIN; ZINC; ZINC SULFATE;

AMINO ACID SEQUENCE; CELL VIABILITY; CHANNEL GATING; CONCENTRATION RESPONSE; DARK ADAPTATION; DIET SUPPLEMENTATION; DIETARY INTAKE; ELECTRORETINOGRAM; GLAUCOMA; HUMAN; NERVE CELL DEGENERATION; NEUROPROTECTION; NEUROTRANSMISSION; NIGHT BLINDNESS; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINA ISCHEMIA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; TISSUE DISTRIBUTION; ZINC DEFICIENCY;

ANIMALS; HUMANS; NEUROPROTECTIVE AGENTS; RETINA; ZINC;

EID: 0035372630     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(00)00057-5     Document Type: Review

References (242)

1. Selective modulation of NMDA responses by reduction and oxidation
2. Ocular circulation
3. In vitro retina as an experimental model of the central nervous system
4. Selective release of endogenous zinc from the hippocampal mossy fibers in situ
5. 2+ from brain tissue during activity
6. Excitation-transcription coupling mediated by zinc influx through voltage-dependent calcium channels
7. Nonvesicular release of neurotransmitter
8. Neurotrophins: A family of proteins supporting the survival of neurons
9. Zinc ion binding to human brain calcium binding proteins, calmodulin and S100b protein
10. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerabral microdialysis
11. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex
12. Zinc and selenium, site-specific versus general antioxidation
13. Ionotropic glutamate receptors
14. Effects of antioxidants on ischemic retinal dysfunction
15. Retinal photoreceptor-pigment epithelium interactions
16. Selective synaptic distribution of kainate receptor subunits in the two plexiform layers of the rat retina
17. Diversity of glutamate receptors in the mammalian retina
18. The physiological role of zinc as an antioxidant
19. Zinc changes AMPA receptor properties: Results of binding studies and patch clamp recordings
20. Mechanisms of neuronal damage in brain hypoxia/ischemia: Focus on the role in mitochondrial calcium accumulation
21. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model
22. 2+) blocks voltage gated calcium channels in cultured rat dorsal root ganglion cells
23. Ocular histopathology of acrodermatitis enteropathica
24. Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit
25. Retinal neurones containing kainate receptors are influenced by exogenous kainate and ischaemia while neurones lacking these receptors are not - Melatonin counteracts the effects of ischaemia and kainate
26. 2+ in the hippocampal mossy fiber zone of the rat in situ
27. Protection against free radical-induced and transition metal-mediated damage: The use of 'pull' and 'push' mechanism
28. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage
29. Calcium and excitotoxic neuronal injury
30. Zinc and brain injury
31. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons
32. Response of olfactory Schwann cells to intranasal zinc sulfate irrigation
33. Glucocortiocoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death
34. The role of NMDA and non-NMDA excitatory amino acid receptors in the functional organization of primate retinal ganglion cells
35. Zinc deficiency, ethanol, and myocardial ischemia affect lipoperoxidation in rats
36. Neurotoxic action of kainic acid
37. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea
38. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction
39. Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes
40. Zinc metabolism in the brain: Relevance to human neurodegenerative disorders
41. The autometallographic zinc-sulphide method
42. Free radicals and neuronal cell death
43. +-ATP'ase
44. Contribution of third-order retinal neurons to the electroretinogram (ERG) b-wave in the rabbit retina
45. The rate of rhodopsin regeneration in the bleached eyes of zinc-deficient rats in the dark
46. Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents
47. Ischaemia and reperfusion-induced injury in rat retina obtained from normotensive and spontaneously hypertensive rats: Effects of free radical scavengers
48. Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional guamanian methods
49. Tubulin-zinc interactions: Binding and polymerization studies
50. Metallothioneins and other zinc-binding proteins in brain
51. Elemental concentrations in ocular tissues of various species
52. Effect of an acute zinc depletion on rat lipoprotein distribution and peroxidation
53. Therapeutic potential on NMDA receptor antagonists as neuroprotective agents
54. Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase
55. Combined kainate and ischemia produces 'mesial temporal sclerosis'
56. Neurobiology of zinc and zinc-containing neurons
57. A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain
58. Loss of zinc staining from hippocampal mossy fibers during kainic acid induced seizures: A histofluorescence study
59. Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states
60. The visual cycle
61. NMDA receptor redox sites: Are they targets for selective neuronal protection
62. Mannitol, dextromethorphan, and catalase minimise ischemic damage to retinal pigment epithelium and retina
63. Reoxygenation injury and antioxidant protection: A tale of two paradoxes
64. Reactive oxygen species and the central nervous system
65. Antioxidants in human health and disease
66. Antioxidants and human disease: A general introduction
67. Role of free radicals and catalytic metal ions in human disease: An overview
68. Biologically relevant metal ion-dependent hydroxyl radical generation. An update
69. Lipid peroxidation: Its mechanism, measurement, and significance
70. Modulation of glycine receptors in retinal ganglion cells by zinc
71. Effect of anoxia on ion distribution in the brain
72. 2+: An endogenous modulator of ligand- and voltage-gated ion channels
73. Studies on the reaction catalyzed by transport (Na, K) adenosine triphosphatase. I. Effect of divalent metals
74. Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia
75. Histochemical localization of zinc and copper in rat ocular tissues
76. Responses of pyriform cortex neurons to excitatory amino acids: Voltage dependence, conductance changes and effects of divalent cations
77. Stimulation-induced uptake and release of zinc in hippocampal slices
78. Identification and characterization of zinc binding sites in protein kinase C
79. Effects of zinc deficiency on the oxidation of retinol and ethanol in rats
80. 2+ on muscle glycolysis and their reversal by histidine
81. 2+-dependent collapse of mitochondrial membrane potential and ultrastructural alteractions of mitochondria
82. The presence of zinc-binding proteins in brain
83. Glycine potentiates the NMDA response in cultured mouse brain neurons
84. Zinc in the eye
85. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species
86. Protective action of zinc against glutamate neurotoxicity in cultured retinal neurons
87. The protection of the retina from ischemic injury by the free radical scavenger EGb 761 and zinc in the cat retina
88. 2+ entry produces oxidative neuronal necrosis in cortical cell cultures
89. Zinc-induced cortical neuronal death with features of apoptosis and necrosis: Mediation by free radicals
90. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes
91. 2+ ions on mitochondrial electron transport
92. Neurobiology of ischaemic brain damage
93. Effect of anticonvulsant drugs on glutamate neurotoxicity in cortical cell culture
94. Zinc alters excitatory amino acid neurotoxicity on cortical neurons
95. Zinc toxicity on cultured cortical neurons: Involvement of N-methyl-D-aspartate receptors
96. The role of zinc in selective neuronal death after transient global cerebral ischemia
97. Calcium-related damage in ischemia
98. Calcium in ischemic cell death
99. 2+ ions with glyceraldehyde-3-phosphate dehydrogenase from bovine heart and rabbit muscle
100. + channels by external divalent cations is modulated by intracellular ATP. Evidence for allosteric regulation of the channel protein
101. Ameliorative effect of MK-801 on retinal ischemia
102. Modulation by zinc ions of native rat and recombinant human inhibitory glycine receptors
103. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes
104. Zinc protects against ultraviolet A1-induced DNA damage and apoptosis in cultured human fibroblasts
105. Brain lesions induced by specific and non-specific inhibitors of sodium-potassium ATPase
106. The neurotoxicity of zinc in the rat hippocampus
107. Effect of metal chelating agents on the direct and seizure-related neuronal death induced by zinc and kainic acid
108. The inhibition of single N-methyl-D-aspartate-activated channels by zinc ions on cultured rat neurones
109. Der Zinkgehalt in den Augen von Knochfischen
110. The effect of severe zinc deficiency on the morphology of the rat retinal pigment epithelium
111. Effect of lipid peroxidation inhibition on retinal ganglion cell death
112. Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons
113. Antioxidant enzymes in the aging human retinal pigment epithelium
114. Zinc ions inhibit the QP center of bovine heart mitochondrial bc1 complex by blocking a protonatable group
115. Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells
116. Association of zinc and antioxidant nutrients with age-related maculopathy
117. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc
118. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues
119. Glutamate receptors of ganglion cells in the rabbit retina: Evidence for glutamate as a bipolar cell transmitter
120. N-methyl-D-aspartate receptors of ganglion cells in rabbit retina
121. Effect of systemic zinc administration on delayed neuronal death in the gerbil hippocampus
122. The mechanisms of insulin-like effects of ionic zinc
123. The physiology of excitatory amino acids in the vertebrate central nervous system
124. Pharmacologic properties of NMDA receptors
125. N-methyl-D-aspartic acid receptor structure and function
126. Alterations in zinc, vitamin A, and retinol-binding protein in chronic alcoholics: A possible mechanism for night blindness and hypogonadism
127. Zinc-deficiency-induced retinal dysfunction in Crohn's disease
128. Functional consequences of zinc deficiency
129. Ischaemic brain damage-prevention with competitive and non-competitive antagonists of N-methyl-D-aspartate receptors
130. 2+ channels
131. Zinc deficiency and corticosteroids in the pathogenesis of alcoholic brain dysfunction - A review
132. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo
133. Light-induced changes in S-antigen (arrestin) localization in retinal photoreceptors: Differences between rods and cones and defective process in RCS rat retinal dystrophy
134. Concomitant activation of two types of glutamate receptor mediates excitation of salamander retinal ganglion cells
135. Zinc deficiency: A cause of abnormal dark adaptation in cirrhotics
136. 2+
137. Limited but evident protective effects of MK-801 and pentobarbital on neuronal damage following forebrain ischemia in the gerbil under normothermic conditions
138. Effects of divalent metal ions on alveolar macrophage membrane adenosine triphosphatase activity
139. Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase
140. Zinc potentiation of neurotransmission and inhibition of background cationic conductance in rat cultured hippocampal neurones
141. Effects of ischaemia on neurotransmitter release from the isolated retina
142. The Muller cell: A functional element of the retina
143. Oral zinc in macular degeneration
144. Zinc content of human retinal pigment epithelium decrease with age and macular degeneration while superoxide dismutase activity increases
145. Inhibition of nonphosphorylating electron transfer by zinc. The problem of delineating interaction sites
146. Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress
147. Mediation by membrane protein kinase C of zinc-induced oxidative neuronal injury in mouse cortical culture
148. Extracellular neuroactive amino acids in the rat striatum during ischaemia: Comparison between penumbral conditions and ischaemia with sustained anoxic depolarization
149. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
150. Neurotoxity of excitatory amino acids
151. Kainic acid: A powerful neurotoxic analogue of glutamate
152. MK-801 powerfully protects against N-methyl-aspartate neurotoxicity
153. Protection of the transiently ischemic cat retina by zinc-desferrioxamine
154. Mechanisms of calcium-related cell death
155. Neuroprotection to the retina: Relevance to glaucoma
156. Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia
157. The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina
158. Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocysteic acid-induced release of GABA in the rabbit retina
159. Influence of excitatory amino acids and ischemia on rat retinal choline acetyltransferase-containing cells
160. The effect of kainate on protein kinase C, GABA, and the uptake of serotonin in the rabbit retina in vivo
161. Protection of rabbit retina from ischemic injury by flupirtine
162. Melatonin protects against ischaemic-like insults to retinals cells, in vivo
163. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent
164. Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirtine
165. Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist
166. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
167. Neuroprotection in relation to retinal ischemia and relevance to glaucoma
168. Ganglion cell death in glaucoma: What do we really know
169. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc
170. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - A review of preclinical data
171. Ocular ischemia and the effects of allopurinol on functional recovery in the retina of the arterially perfused cat eye
172. Distribution of glutamate receptor subtypes in the vertebrate retina
173. 2+ ion
174. Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons
175. Discovery of human zinc deficiency and studies in an experimental human model
176. Zinc: An overview
177. GABA receptors of bipolar cells from the skate retina: Actions of zinc on GABA-mediated membrane currents
178. Zinc has opposite effects on NMDA and non-NMDA receptors expressed in Xenopus oocytes
179. Pharmacological actions of melatonin in oxygen radical pathophysiology
180. Suppression of oxygen toxicity by melatonin
181. Modulation of NMDA receptor responsiveness by neurotransmitters, drugs and chemical modification
182. Effect of zinc supplementation on resistance of cultured human skin fibroblasts toward oxidant stress
183. Interrelationship between retinal ischaemic damage and turnover and metabolism of putative amino acid neurotransmitters, glutamate and GABA
184. Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins
185. Acquired dyschromatopsia in glaucoma
186. 2+ transported by the mitochondrial calcium uniporter
187. The S100 family of EF-hand calcium-binding proteins: Functions and pathology
188. The ON and OFF channels of the visual system
189. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene
190. Zinc mining for protein domains
191. Excitotoxic models for neurodegenerative disorders
192. Hydroxyl radical production in iron-cysteine solutions and protection by zinc
193. 2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production
194. + and inhibition of glycolysis
195. Effect of zinc supplementation on plasma levels of vitamin A and retinol-binding protein in malnourished children
196. Zinc causes an apparent increase in rhodopsin phosphorylation
197. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology
198. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment
199. Push-pull model of the primate photopic electroretinogran: A role for hyperpolarizing neurons in shaping the b-wave
200. Inhibition of the respiratory chain by zinc ions
201. A selective loss of hippocampal mossy fiber Timm stain accompanies granule cell seizure activity induced by perforant path stimulation
202. 2+-stimulated sphingomyelinase in fetal bovine serum
203. Inhibition of glutathione peroxidase by cadmium and other metal ions
204. 73 active-site zinc complex in latency and 'cysteine switch' mechanism for activation
205. Detection of pathological zinc accumulation in neurons: Methods for autopsy, biopsy, and cultured tissue
206. Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury
207. Modification of reperfusion-induced ionic imbalance by free radical scavengers in spontaneously hypertensive rat retina
208. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake
209. Calcium antagonist effects on low-threshold (T-type) calcium current in rat isolated hippocampal CA1 pyramidal neurons
210. Metallothionein shows an aged-related decrease in human macular retinal pigment epithelium
211. Influences of zinc on selected cellular functions of cultured human retinal pigment epithelium
212. Zinc induces catalase expression in cultured fetal human retinal pigment epithelial cells
213. Possible for metallothionein protection against human retinal pigment epithelium
214. Die normalen Schwer-metalle der niere
215. Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat
216. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit
217. The localisation of endogenous zinc and the in vitro effect on the GABA immunoreactivity and formation of reactive oxygen species in the retina
218. The localisation of zinc in rat photoreceptors varies during light and dark adaptation
219. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor
220. The biochemical basis of zinc physiology
221. Zinc metallochemistry in biochemistry
222. Immunohistochemical distribution of neurotrophins and their receptors in the rat retina and the influence of ischaemia reperfusion
223. NMDA induces BDNF expression in the albino rat retina in vivo
224. Permeation by zinc of bovine chromaffin cell calcium channels: Relevance to secretion
225. Extracellular glutamate during focal cerebral ischaemia in rats: Time course and calcium dependency
226. Zinc: Health effects and research priorities for the 1990s
227. Proton probe microanalysis in biology: General principles and applications for the study of Alzheimer's Disease
228. 2+ antagonize NMDA and GABA responses of hippocampal neurons
229. + current in the medial entorhinal cortex
230. Effects of inhibiting glutamine synthetase and blocking glutamate uptake on b-wave generation in the isolated rat retina
231. Induction of apoptosis in cultured human retinal pigmented epithelial cells: The effect of protein kinase C activation and inhibition
232. Localization and modulatory actions of zinc in vertebrate retina
233. Evidence that zinc inhibits N-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding
234. 2+) permeable AMPA/kainate channels and triggers selective neurol injury
235. Brief exposure to zinc is toxic to cortical neurons
236. Dextromethorphan protects retina against ischemic injury in vivo
237. High vulnerability of GABA-immunoreactive neurons to kainate in rat retinal cultures: Correlation with the kainate-stimulated cobalt uptake
238. 2+ exchange currents in cortical neurons: Concomitant forward and reverse operation and effect of glutamate
239. Zinc protoporphyrin, zinc ion, and protoporphyrin reduce focal cerebral ischemia